Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
BeiGene Ltd ( (HK:6160) ) has provided an announcement.
BeOne Medicines Ltd., a Swiss corporation listed on the Hong Kong Stock Exchange, announced the grant of 21,274 Restricted Share Units (RSUs) to 147 employees under its 2016 Share Option and Incentive Plan. This grant represents approximately 0.02% of the company’s total issued shares. The RSUs will vest over four years, subject to continued employment, with specific conditions for accelerated vesting in certain cases. This move is part of the company’s strategy to incentivize and retain talent, potentially impacting its operational efficiency and market competitiveness.
The most recent analyst rating on (HK:6160) stock is a Hold with a HK$211.00 price target. To see the full list of analyst forecasts on BeiGene Ltd stock, see the HK:6160 Stock Forecast page.
More about BeiGene Ltd
Average Trading Volume: 4,875,681
Technical Sentiment Signal: Buy
Current Market Cap: HK$298.3B
See more insights into 6160 stock on TipRanks’ Stock Analysis page.